Background. Pregnancy-associated malaria is known to modify fetal immunity. Most previous studies have been cross-sectional in nature and have focused on the priming of acquired immune responses in utero. In this context, the influence of the timing and/or duration of placental infection with Plasmodium falciparum are unknown, and changes to innate immune responses have not been studied extensively.
In areas where malaria is endemic, young and primigravid pregnant women have a much higher risk of infection with Plasmodium falciparum than do other adults in the same population [1, 2] . Pregnancyassociated malaria is now recognized as a prominent risk factor for poor pregnancy outcomes in such areas [3] [4] [5] [6] [7] . Recent studies indicate that regulatory T cells and cytokines may play an important role in successful outcomes of pregnancy [8, 9] and that pregnancy-associated malaria is associated with increased placental-blood plasma levels of tumor necrosis factor-␣ (TNF-␣) [10, 11] , interleukin-12 (IL-12), and interferon-␥ (IFN-␥) and, in some studies, with lower levels of IL-10 [12, 13] , an immunological environment that would be predicted to have adverse effects on pregnancy.
P. falciparum infection affects not only pregnancy outcomes but may also influence the development of neonatal immune responses. P. falciparum infection during pregnancy leads to immune priming to plasmodial antigens in utero, resulting in increased levels of specific cytokines, including Th1, and antibody production detectable in cord blood mononuclear cells (CBMCs) in vitro [14 -19] . Most studies of P. falciparum infection during pregnancy have investigated the effects of parasites on acquired parasite-specific responses in the newborn, with very few addressing the influence of the infection on innate immune activity.
Although the majority of studies of pregnancyassociated malaria have been cross-sectional in nature, it is increasingly apparent that the history of malaria during pregnancy is important [20] and, thus, that longitu-dinal studies are needed. P. falciparum infections during pregnancy can be characterized as either chronic (i.e., placental parasitemia at birth accompanied by intracellular hemozoin) or acute (i.e., parasitemia with or without small amounts of intracellular pigment), with potentially different consequences. For example, unlike acute infections, chronic infections are commonly associated with low birth weight [3, 21, 22] . The question of how a woman's history of malaria affects innate immune responses during pregnancy has not been addressed before and is expected to be an important determinant of neonatal responses following exposure to pathogens or vaccines.
In the study presented here, we conducted active monthly follow-up of women during pregnancy to accurately characterize their history of malaria. We investigated aspects of the innate immune response of cord blood cells, namely cytokine responses, following stimulation with Toll-like receptor (TLR) ligands, as a function of maternal plasmodial parasite infection history and maternal parity. Such responses are important because TLR/TLR ligand interactions will potentially determine the outcome of encounters with pathogens early in life.
SUBJECTS, MATERIALS, AND METHODS
The study took place at the Medical Research Unit of Albert Schweitzer Hospital, in Lambaréné, Gabon, from May 2003 through July 2004. Two antenatal clinics serve the inhabitants of this area and its vicinity. Malaria in the region is hyperendemic and perennially transmitted, and the disease is predominantly due to P. falciparum [23, 24] . The prevalence of HIV infection among pregnant women during the study period was 4% (data were kindly provided by the local mother-to-child HIV transmission program).
Pregnant women in the second trimester of pregnancy (defined as weeks 16 -28 of gestation) who were visiting an antenatal clinic were invited to participate in the study. After participants provided written informed consent, they were examined by study physicians and advised to report to the study center for any malaria-like symptoms and to participate in active monthly follow-up visits up to the time of delivery, to allow the detection of P. falciparum infections. All women found to be infected with P. falciparum were treated with oral quinine (30 mg/kg/day) for 7 days and were followed up as described elsewhere [25] . Despite the high prevalence of chloroquine resistance in the area [26] , pregnant women took this agent as prophylaxis, in accordance with the national guidelines. Intermittent preventive treatment during pregnancy was not yet implemented at the time of the study [27] .
The study was approved by the ethics committee of the International Foundation of the Albert Schweitzer Hospital.
Sample collection. Immediately after placental expulsion following delivery, 10 mL of venous cord blood was drawn into a heparinized tube directly via puncture of the ethanol-sterilized umbilical vein at a site distal to the placenta, to minimize the possibility of cross-contamination of maternal and cord blood. Placental blood (for slide-smear microscopic detected of P. falciparum) and placental tissue (preserved at Ϫ80°C for submicroscopic detection of P. falciparum by quantitative polymerase chain reaction [qPCR]) was collected from the placental intervillous spaces. Additionally, 2 mL of EDTA-anticoagulated maternal peripheral blood was collected for measurement of hemoglobin, as described elsewhere [28] , and for slide smear to detect plasmodial parasites microscopically.
P. falciparum detection. Parasites were detected microscopically and quantified using a previously described method [29] . This method was used for maternal blood obtained via finger prick at follow-up visits throughout pregnancy, blood collected at delivery, placental blood, and cord blood.
No placental histological examination was undertaken, but placental tissue was examined for the presence of P. falciparum, using reverse transcription (RT)-qPCR as described elsewhere [3, 5] . A cycle threshold (CT) of 40 was set as the limit for P. falciparum-positive samples. Parasite levels were considered high if the CT was Ͻ30, whereas levels were considered low if the CT was 30 -40.
Classification of subgroups according to maternal infection history and parity. For comparative analysis, distinct groups were created on the basis of whether P. falciparum was detected by microscopy during follow-up and delivery. The negative group consisted of 107 women in whom P. falciparum was not detected microscopically during follow-up or delivery, the treated group consisted of 54 women with P. falciparum malaria treated successfully during pregnancy in whom P. falciparum was not detected microscopically in placental and/or maternal peripheral blood at delivery, the positive-treated group consisted of 19 women with P. falciparum malaria treated during pregnancy in whom P. falciparum was detected microscopically in placental and/or maternal peripheral blood at delivery, and the positive group consisted of 14 women without P. falciparum malaria during pregnancy in whom the parasite was detected microscopically in placental and/or maternal peripheral blood at delivery. Detection of P. falciparum at the time of delivery in the positive group indicated recent acquisition of the parasite (i.e., between the last follow-up visit and delivery).
To assess the influence of no, low, or high levels of placental malaria parasites on immunological activity, 3 subgroups corresponding to these levels were created. Group A consisted of 144 women in whom no parasites were detected in placental blood by microscopy or qPCR (CT, Ͼ40). Group B consisted of 19 women with low parasite levels detected by qPCR (CT, 30 -40) and either no parasites (i.e., submicroscopic infection [n ϭ 17]) or low levels of parasites (n ϭ 2) detected by microscopy. Group C consisted of 31 women in whom parasites were detected by microscopy and qPCR (CT, Ͻ30).
To assess the effect of parity on cord responses, primiparous mothers (i.e., women who gave birth for the first time) were compared with multiparous mothers (i.e., those who gave birth at least a second time).
CBMC isolation. CBMCs were separated from freshly collected heparin-anticoagulated blood by density centrifugation over Ficoll-Paque, as described elsewhere [14] , and cultured at density of 1 ϫ 10 6 cells per well in Iscove's medium (Invitrogen-Life Technologies) containing 10% fetal calf serum (Greiner Bio-One) at 37°C and 5% CO 2 . Culture conditions were optimized with respect to concentrations of stimuli and sampling times. Cells were stimulated with medium alone, phytohemagglutinin (PHA; 2 g/mL [BioTrading Benelux]), lipopolysaccharide (LPS; 100 ng/mL [Sigma-Aldrich Chemie]), or polyinosine-polycytidylic acid (Poly I:C; 50 g/mL [InvivoGen]). Supernatants were collected after 3 days of culture, aliquoted, and kept at Ϫ20°C until transport to the Netherlands, where levels of cytokines (i.e., IL-5, IL-10, TNF-␣, and IFN-␥) were determined using a multiplex bead assay method (Luminex 100). The human cytokine antibody bead kits were obtained commercially (BioSource). Samples with cytokine concentrations below the detection limit were given the value corresponding to the detection limit of the assay as indicated by the supplier (3 pg/mL for IL-5, 5 pg/mL for IL-10, 5 pg/mL for IFN-␥, and 10 pg/mL for TNF-␣). Data throughout are expressed as medians with interquartile ranges (IQRs).
Statistical analysis. Data were collated in FileMaker Pro 5 (FileMaker) and transferred to SPSS for Windows, version 14.0 (SPSS), for statistical analysis. Segregation of groups according to cytokine responsiveness was done using the median value as a cutoff. Thus, responses greater than the median concentration were considered high, and responses less than the median concentration were considered low.
Normally distributed variables were analyzed using a 1-way analysis of variance t test for Ͼ2 variables, and the independent sample t test statistic was used to compare 2 variables. Cytokine data that were not normally distributed even after logtransformation were analyzed by the nonparametric KruskalWallis test for comparison of Ͼ2 variables and the MannWhitney U test for comparison of 2 variables. When comparing differences between proportions, the Pearson 2 test was performed. Statistically significant differences were considered to be at the level of P Ͻ .05. Relative risks obtained by logistic regression are expressed in odds ratios (ORs) with 95% confidence intervals (CIs).
RESULTS
Characteristics of the study population. Of the 194 women in the study, 33 (17%) had P. falciparum detected by microscopy of a placental blood specimen and/or a maternal peripheral blood specimen obtained at delivery. Of these 33 women, 14 (42%) presented with parasitemia at delivery only (the positive group), whereas 19 (58%) had received treatment for infection during pregnancy (the positive-treated group). For the remaining 161 women, samples obtained at delivery were negative for P. falciparum; 54 (28%) were from mothers treated for P. falciparum infection during pregnancy (i.e., the treated group), and samples from 107 (55%) were from women with no evidence of P. falciparum infection at any time (i.e., the negative group). Among mothers in the latter 2 groups, samples from 17 (11%) of 161 tested positive for P. falciparum by submicroscopic analysis. All microscopy-positive samples were also positive for P. falciparum by submicroscopic analysis. No malarial parasites were detected microscopically in cord blood specimens. Demographic, hematologic, and parasitologic characteristics of the participants are summarized in table 1 .
CBMC cytokine responses, by microscopy findings in maternal samples. In response to both Poly I:C and LPS, the median levels of IFN-␥ produced by CBMCs of neonates born to mothers in the positive group were significantly greater than the median levels for neonates born to mothers in the treated or negative groups (figure 1). CBMCs of neonates born to mothers in the positive-treated group produced the second highest median levels of IFN-␥ in response to Poly I:C (figure 1A) and LPS (figure 1B), but the levels were not significantly different from those produced in neonates born to mothers in the other groups.
The profile of TNF-␣ production in response in CBMCs to each TLR ligand was significantly different across the 4 groups (figure 2). The median TNF-␣ response by CBMCs of neonates born to mothers in the positive group was significantly lower than that of CBMCs of neonates born to mothers in the other groups. As for IFN-␥, no statistically significant influence of the apparent duration of maternal P. falciparum infection on the production of TNF-␣ was discernible between the positive and positive-treated groups.
In response to PHA, the median amount of IFN-␥ produced by CBMCs differed significantly between the groups, with the highest levels observed in neonates born to mothers in the positive group, followed by neonates born to mothers in the positive-treated group, those born to mothers in the treated group, and those born to mothers in the negative group (table 2) . Evaluation of PHA-induced TNF-␣ production by CBMCs according to maternal infection history, however, revealed no differences.
IL-10 responses by CBMCs to Poly I:C and LPS and to the nonspecific mitogen PHA did not differ between groups. IL-5 responses to the 3 stimuli were low in all groups.
CBMC responses, by RT-qPCR to determine placental parasite density. To determine whether submicroscopic P. falciparum infections of the placenta have a substantial effect on immunological responsiveness of neonates, the presence of malaria infections was detected by qPCR in placental biopsy samples. The comparison of the responses to TLR ligands in the group with no, low, or high grades of infection (defined by CT values determined by qPCR) showed that high levels of P. falciparum (31 [94%] of which were microscopic), rather than low levels of infection (17 [89%] of which were submicroscopic), significantly affected the immunological outcomes of CBMCs after stimulation with TLR ligands ( figure 3) .
Cytokine responses by CBMCs, by parity. There were significant differences in cytokine production by CBMCs of neonates born to primiparous and multiparous mothers. The concentrations of IFN-␥, TNF-␣, and IL-10 produced by CBMCs of neonates born to primiparous women were substantially higher than those produced by CBMCs of neonates born to multiparous women in response to Poly I:C and in response to PHA. Although no influence on IFN-␥ responses to LPS was seen, the amount of TNF-␣ and IL-10 produced by CBMCs of neonates born to primiparous women in response to LPS was significantly higher than that produced by CBMCs of neonates born to multiparous mothers (table 2) .
Factors governing patterns of cytokine responses to TLR ligands. In univariate analyses, neonates born to mothers in the positive group were Ͼ7 times and Ͼ5 times more likely to produce high levels of IFN-␥ in response to Poly I:C and LPS, respectively (table 3) . A higher IFN-␥ response was more likely if the neonate was born to a primiparous mother, but this likelihood was not statistically significantly different from that for neonates born to multiparous mothers (OR, 1.7; 95% CI, 0.9 -3.4). Although it is known that primiparous mothers have an increased risk of malaria, multivariate modeling revealed a significant independent effect of P. falciparum infection on a high IFN-␥ response to TLR ligands. Use of the same analysis to investigate TNF-␣ data revealed that CBMCs of children born to mothers in the positive group were the least likely (by at least 75%) to produce high levels of TNF-␣ in response to either Poly I:C or LPS (table 4) . Delivery by a primiparous mother significantly increased the chance (by 2-fold) of a high TNF-␣ response to Poly I:C, with a similar but nonsignificant increase (1.6-fold) for LPS (table 4). In the multivariate model, after adjustment for parity, maternal infection status remained associated with the TNF-␣ response to TLR ligands. An increased risk of a higher CBMC TNF-␣ response to Poly I:C if born to a primiparous mother also remained an independent and statistically significant outcome (table 4) .
DISCUSSION
This cohort study, which carefully followed up mothers during pregnancy, allowed for the accurate categorization of these women according to their malaria history. Examination of innate immune responses in cord blood indicated a profound modification of responses to TLR ligands in neonates born to mothers with P. falciparum infection. The most marked effects on cytokine responses to TLR ligands were seen in CBMCs of neonates born to mothers recently infected with P. falciparum. Infection occurring late during pregnancy will inevitably result in transplacental transfer of parasite components, some of which may affect TLR responsiveness [16, 19, 20, 30] . A recent study of adult European volunteers infected with P. falciparum [31] and our study of chronically infected Ghanaian children (Hartgers et al., unpublished data) have shown that TLR responsiveness is altered upon P. falciparum infection. Our results here indicate that neonatal cells, like cells from children or adults, show an altered innate immune response to TLR ligands when exposed to components of P. falciparum. The type of changes in the innate immune responses in neonates might, however, be different from those in children and adults. In neonates born to mothers recently infected with P. falciparum, IFN-␥ production by CBMCs in response to both TLR3 (Poly I:C) and TLR4 (LPS) ligands was significantly higher, but the TNF-␣ production stimulated by these same ligands was significantly lower than that of cells of neonates born to mothers without P. falciparum infection at delivery. These low responses are TLR specific, as demonstrated by the production of equivalent amounts of TNF-␣ by CBMCs of all groups following nonspecific stimulation of CBMCs with PHA (table 2) .
A number of studies have examined TNF-␣ activity in neonates and the effect of maternal P. falciparum infection on this cytokine [32] [33] [34] . One such study examined cord plasma and observed a tendency for lower levels of TNF-␣ in samples from neonates born to mothers with P. falciparum infection at delivery [32] . In the study reported by Engelmann et al. [35] , CBMCs from an equivalent group of neonates had a lower proportion of TNF-␣-positive ␥␦ T cells and a higher proportion of IFN-␥-positive ␥␦ T cells in response to PMA/ionomycin, compared with CBMCs of other groups. Because PMA/ionomycin can activate partially overlapping signaling cascades, these results can be seen as consistent with our observations here. However, a study conducted in the Gambia [36] reported lower LPSinduced IFN-␥ and IL-12 activity by CBMCs of neonates born to P. falciparum-infected mothers. It should be noted that the latter study was comparatively limited with respect to sample size and detailed history of infection during pregnancy, and it used LPS concentrations that were 10 times higher. Importantly, our findings are in line with LPS responses of CBMCs from a population of white individuals, which showed TNF-␣ and IFN-␥ responses Table 2 . Cytokine production by cord blood mononuclear cell specimens obtained from neonates and stimulated with Toll-like receptor ligands and phytohemagglutinin (PHA). similar to those seen in Gabonese women without P. falciparum infection during pregnancy (data not shown). This supports the proposition that in utero exposure to P. falciparum infection is an important modulator of innate immune responses in neonates, leading to higher IFN-␥ along with lower TNF-␣ responses to TLR ligands. The finding that P. falciparum infections acquired during the last month of pregnancy enhance IFN-␥ production to TLR ligands on the one hand while leading to suppressed TNF-␣ production on the other might be explained by different production dynamics for these cytokines: after TLR ligation, there is an early peak of TNF-␣ followed by a more rapid decrease, whereas for IFN-␥ there is a gradual and proportional increase. However, it is also possible that the signaling pathway leading to TNF-␣ production as a result of TLR activation is distinct from that of IFN-␥ production. Of note here is the knowledge that certain molecules, including adenosine and so-called "negative" acutephase proteins, specifically suppress TNF-␣ production [37] .
One may speculate that placental P. falciparum infection and the consequent stress on the fetus may lead to enhanced production of such molecules by the fetus, offering a possible explanation for the reduced TNF-␣ activity of CBMCs we observed in that group.
The data we present here suggest that the most profound effects of maternal P. falciparum infection during pregnancy on neonatal innate immune responses are related to recently acquired infections (i.e., those acquired 1 month before delivery). It was notable in this context that the responses to TLR ligands of CBMCs of neonates born to mothers successfully treated for malaria during pregnancy were similar to those of neonates born to mothers with no evidence of infection during pregnancy. Earlier studies have reported enhanced P. falciparum antigen-specific and -nonspecific IFN-␥ responses in CBMCs of infants born to successfully treated mothers [20] . Not unexpectedly, this is an indication that the responses to TLR ligands reported here reflect a different spectrum of cytokine production capacity in any given CBMC sample and that innate responses are differentially affected than adaptive responses by length of exposure to an infection during pregnancy.
Further observations of particular note in this study concern the significant association, independent of that found for recent maternal P. falciparum infection, between the tendency for higher CBMC responses to a TLR ligand (Poly I:C) and primiparity. This finding accords with that of Malhotra et al. [18] , who reported a bias toward production of higher cytokines in response to parasite-specific antigen stimulation by CBMCs from newborns of primigravid women. However, we have shown that there is an independent effect of primiparity; thus, the higher responses of CBMCs of firstborns might reflect a true intrinsic property of first live births. We have, in addition, demonstrated that low-grade placental infections, the majority of which were detected submicroscopically only, appear not to influence the innate immune responses of neonatal cells. It would have been interesting to determine whether hemozoin in placental tissue affects the associations found in the current study, because hemozoin has been shown to activate innate immune responses of human and murine cells [38, 39] . However, we were unable to include histological examination of the placenta in our study. Finally, no data were obtained on maternal HIV infection status in this study. There are indeed reports of an association between pregnancy-associated malaria and maternal HIV infection [40] , but we consider it likely that any such influence in this study was negligible, because of the low prevalence of HIV infection in this essentially rural population.
In conclusion, in this study, which incorporated careful follow-up of mothers during pregnancy, we identified recently acquired P. falciparum infection as having a clear, measurable influence on neonatal innate immune responsiveness. This may have implications for pregnancy outcome but is expected to have even more-important consequences for infants in early life.
